Understanding how glioblastoma interacts with neurons and immune cells
Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu
This study is looking at how glioblastoma cells interact with brain cells and immune cells to see how these relationships affect tumor growth and treatment, with the goal of finding new ways to help patients with this type of brain cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10930062 on NIH RePORTER |
What this research studies
This research investigates the complex interactions between glioblastoma cells, neurons, and immune cells to better understand how these relationships affect tumor growth and response to treatment. By developing a systems-level model, the research aims to analyze how tumor cells influence neural signaling and how immune cells interact with the tumor microenvironment. The approach includes using various biological models and computational methods to simulate these interactions, ultimately aiming to identify new therapeutic strategies that could improve treatment outcomes for patients with glioblastoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are seeking innovative treatment options.
Not a fit: Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for glioblastoma, potentially improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in understanding tumor-immune interactions, suggesting that this approach could yield valuable insights and advancements in glioblastoma treatment.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: White, Forest M — Massachusetts Institute of Technology
- Study coordinator: White, Forest M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.